Short Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Increases By 154.5%

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) saw a significant increase in short interest in February. As of February 15th, there was short interest totalling 11,200 shares, an increase of 154.5% from the January 31st total of 4,400 shares. Based on an average daily volume of 10,100 shares, the days-to-cover ratio is presently 1.1 days.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

Institutional investors and hedge funds have recently made changes to their positions in the company. Crowley Wealth Management Inc. purchased a new position in ProShares Ultra Nasdaq Biotechnology during the 4th quarter valued at about $51,000. Tower Research Capital LLC TRC boosted its stake in shares of ProShares Ultra Nasdaq Biotechnology by 31.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,326 shares of the exchange traded fund’s stock valued at $270,000 after purchasing an additional 1,266 shares in the last quarter. Finally, Jane Street Group LLC increased its holdings in ProShares Ultra Nasdaq Biotechnology by 8.4% during the third quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock valued at $306,000 after buying an additional 374 shares during the period.

ProShares Ultra Nasdaq Biotechnology Trading Up 0.8 %

BIB traded up $0.45 during trading on Friday, hitting $54.08. 2,998 shares of the stock were exchanged, compared to its average volume of 10,036. The firm has a 50 day simple moving average of $53.47 and a 200 day simple moving average of $59.14. ProShares Ultra Nasdaq Biotechnology has a 1 year low of $47.19 and a 1 year high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The company also recently declared a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were paid a dividend of $0.3964 per share. The ex-dividend date of this dividend was Monday, December 23rd. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.